Valuation: RAMM Pharma Corp.

Market Cap 1.19M 852K 743K 702K 637K 81.78M 1.2M 8.41M 3.24M 41.58M 3.2M 3.13M 134M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 336K 293K 276K 251K 32.22M 472K 3.31M 1.28M 16.38M 1.26M 1.23M 52.71M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 day+100.00%
1 week+100.00%
Current month+100.00%
3 months-33.33%
6 months-33.33%
Current year-83.33%
1 week 0.01
Extreme 0.01
0.01
1 month 0
Extreme 0.005
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.6
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Date Insider Type Main position Quantity % Market Cap. Importance
02/06/25 Sell

Chief Executive Officer

4,667,000 3.9091%
21/03/25 Buy

Chief Executive Officer

200,000 0.1675%
21/03/25 Buy

Chief Executive Officer

100,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00%-33.33%-90.00% 852K
+0.04%+3.34%+53.32%+100.52% 1,028B
-0.09%+1.66%+53.24%+66.45% 651B
-0.02%+2.66%+18.65%+71.97% 466B
-1.22%+3.66%+34.59%+38.81% 346B
-0.79%+2.73%+17.73%+25.11% 266B
+0.58%+6.76%+10.58%+17.75% 259B
+1.55%+2.20%+35.12%+45.91% 208B
+0.79%+1.84%-27.55%-56.48% 191B
-0.52%+4.45%+31.57%+98.11% 186B
Average +10.03%+2.93%+19.39%+31.81% 360.17B
Weighted average by Cap. -0.04%+3.09%+34.84%+61.60%

Financials

2024 2025
Net sales 4.34M 3.1M 2.7M 2.55M 2.32M 297M 4.36M 30.57M 11.8M 151M 11.64M 11.38M 487M 3.36M 2.4M 2.09M 1.98M 1.79M 230M 3.37M 23.66M 9.13M 117M 9.01M 8.81M 377M
Net income -16.5M -11.78M -10.27M -9.7M -8.81M -1.13B -16.57M -116M -44.84M -575M -44.25M -43.27M -1.85B -8.91M -6.36M -5.55M -5.24M -4.76M -610M -8.95M -62.73M -24.21M -310M -23.89M -23.36M -998M
Net Debt -626K -447K -390K -368K -334K -42.86M -628K -4.41M -1.7M -21.79M -1.68M -1.64M -70.12M -723K -516K -450K -425K -386K -49.56M -727K -5.09M -1.97M -25.2M -1.94M -1.9M -81.07M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
16/09/26 CA$0.0100 +100.00% 50,000
11/09/26 CA$0.005000 0.00% 5,000
  1. Stock Market
  2. Stocks
  3. RAMM Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!